Clinical Guidelines & Pathways


Migraine Prevention Pathway in Adults (Specialist use only)


For Specialist use only

Updated July 2024

Document History
Approved by BLMK APC Sept 2023

View Document

Guideline Categories: Neurology

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: Anti-CGRP inhibitors, atogepant, Calcitonin gene-related peptide inhibitors, Eptinezumab, Erenumab, Fremanezumab, Galcanezumab, Rimegepant

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net